

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.36673201 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.16470432 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 6.11339756 |
| 4 | glutamate secretion (GO:0014047) | 6.00228544 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.71484975 |
| 6 | vocalization behavior (GO:0071625) | 5.68972391 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.67732198 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.62894866 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.61979842 |
| 10 | locomotory exploration behavior (GO:0035641) | 5.28875521 |
| 11 | nuclear pore complex assembly (GO:0051292) | 5.23680954 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.21061141 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.13853941 |
| 14 | protein localization to synapse (GO:0035418) | 4.99230807 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.97446662 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.95500340 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.90535629 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.85941890 |
| 19 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.85080393 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.80102834 |
| 21 | lipid translocation (GO:0034204) | 4.79006094 |
| 22 | phospholipid translocation (GO:0045332) | 4.79006094 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.62003622 |
| 24 | nuclear pore organization (GO:0006999) | 4.59351910 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.39211649 |
| 26 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.37594428 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.33001902 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.29900078 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.25686357 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.24390388 |
| 31 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.24132877 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 4.20834389 |
| 33 | cellular response to ethanol (GO:0071361) | 4.15296604 |
| 34 | interkinetic nuclear migration (GO:0022027) | 4.15029151 |
| 35 | mature B cell differentiation involved in immune response (GO:0002313) | 4.12175393 |
| 36 | exploration behavior (GO:0035640) | 4.11617012 |
| 37 | pore complex assembly (GO:0046931) | 4.07121437 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.05278680 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.01277986 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.99681132 |
| 41 | regulation of synapse structural plasticity (GO:0051823) | 3.99330721 |
| 42 | negative regulation of DNA repair (GO:0045738) | 3.99044798 |
| 43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.98424855 |
| 44 | neurotransmitter transport (GO:0006836) | 3.95512460 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.93079680 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.91757843 |
| 47 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.89101320 |
| 48 | dosage compensation (GO:0007549) | 3.87720606 |
| 49 | positive regulation of membrane potential (GO:0045838) | 3.86312447 |
| 50 | gamma-aminobutyric acid transport (GO:0015812) | 3.85660109 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.82662583 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81561821 |
| 53 | regulation of neurotransmitter secretion (GO:0046928) | 3.81147573 |
| 54 | mature B cell differentiation (GO:0002335) | 3.80847049 |
| 55 | macroautophagy (GO:0016236) | 3.78308168 |
| 56 | nucleus localization (GO:0051647) | 3.77577040 |
| 57 | proline transport (GO:0015824) | 3.77410949 |
| 58 | positive regulation of neurotransmitter transport (GO:0051590) | 3.77296251 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.77229274 |
| 60 | regulation of protein polyubiquitination (GO:1902914) | 3.76465194 |
| 61 | labyrinthine layer development (GO:0060711) | 3.75932251 |
| 62 | response to histamine (GO:0034776) | 3.75327623 |
| 63 | establishment of nucleus localization (GO:0040023) | 3.74102617 |
| 64 | positive regulation of synapse maturation (GO:0090129) | 3.74081957 |
| 65 | presynaptic membrane organization (GO:0097090) | 3.71988599 |
| 66 | long-term memory (GO:0007616) | 3.71422211 |
| 67 | postsynaptic membrane organization (GO:0001941) | 3.69359131 |
| 68 | regulation of synaptic plasticity (GO:0048167) | 3.67807153 |
| 69 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.67368743 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.64205956 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.64188742 |
| 72 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.62272030 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 3.59704821 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58382930 |
| 75 | activation of protein kinase A activity (GO:0034199) | 3.58097383 |
| 76 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.54784696 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 3.52708604 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.52377952 |
| 79 | layer formation in cerebral cortex (GO:0021819) | 3.51430930 |
| 80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.48359472 |
| 81 | dendritic spine morphogenesis (GO:0060997) | 3.47668315 |
| 82 | central nervous system myelination (GO:0022010) | 3.43943521 |
| 83 | axon ensheathment in central nervous system (GO:0032291) | 3.43943521 |
| 84 | behavioral response to cocaine (GO:0048148) | 3.43551525 |
| 85 | cellular potassium ion homeostasis (GO:0030007) | 3.43009598 |
| 86 | auditory behavior (GO:0031223) | 3.42453199 |
| 87 | regulation of vesicle fusion (GO:0031338) | 3.38279337 |
| 88 | regulation of glutamate secretion (GO:0014048) | 3.38212805 |
| 89 | neuron recognition (GO:0008038) | 3.35977620 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33525981 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.32550472 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.31205495 |
| 93 | regulation of pigment cell differentiation (GO:0050932) | 3.30833109 |
| 94 | neuromuscular process controlling posture (GO:0050884) | 3.30583734 |
| 95 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.29039629 |
| 96 | transmission of nerve impulse (GO:0019226) | 3.24716608 |
| 97 | membrane depolarization (GO:0051899) | 3.24286858 |
| 98 | response to auditory stimulus (GO:0010996) | 3.20604446 |
| 99 | negative regulation of inclusion body assembly (GO:0090084) | 3.20434322 |
| 100 | mechanosensory behavior (GO:0007638) | 3.19869040 |
| 101 | regulation of female receptivity (GO:0045924) | 3.19831768 |
| 102 | histone H3-K36 demethylation (GO:0070544) | 3.19528084 |
| 103 | innate immune response in mucosa (GO:0002227) | 3.19034682 |
| 104 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17134087 |
| 105 | membrane hyperpolarization (GO:0060081) | 3.15942725 |
| 106 | cerebellar granule cell differentiation (GO:0021707) | 3.15752381 |
| 107 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15457609 |
| 108 | protein K48-linked deubiquitination (GO:0071108) | 3.15351846 |
| 109 | synaptic transmission (GO:0007268) | 3.15237847 |
| 110 | regulation of membrane lipid distribution (GO:0097035) | 3.13759996 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13694610 |
| 112 | regulation of synaptic transmission (GO:0050804) | 3.13594378 |
| 113 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.13369789 |
| 114 | nerve growth factor signaling pathway (GO:0038180) | 3.13015553 |
| 115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.12724357 |
| 116 | female mating behavior (GO:0060180) | 3.09467026 |
| 117 | behavioral defense response (GO:0002209) | 3.08807355 |
| 118 | behavioral fear response (GO:0001662) | 3.08807355 |
| 119 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.08146452 |
| 120 | learning (GO:0007612) | 3.08058375 |
| 121 | membrane depolarization during action potential (GO:0086010) | 3.07498241 |
| 122 | Golgi to endosome transport (GO:0006895) | 3.07303423 |
| 123 | positive regulation of cation channel activity (GO:2001259) | 3.07121360 |
| 124 | neuromuscular process controlling balance (GO:0050885) | 3.07077683 |
| 125 | establishment of synaptic vesicle localization (GO:0097480) | 3.03864354 |
| 126 | synaptic vesicle transport (GO:0048489) | 3.03864354 |
| 127 | calcium ion-dependent exocytosis (GO:0017156) | 3.03430787 |
| 128 | B cell receptor signaling pathway (GO:0050853) | 3.03083543 |
| 129 | sodium ion export (GO:0071436) | 3.02845741 |
| 130 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.02390842 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01075726 |
| 132 | histone H3-K9 demethylation (GO:0033169) | 3.00874754 |
| 133 | axonal fasciculation (GO:0007413) | 3.00173371 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 3.00070157 |
| 135 | negative regulation of amino acid transport (GO:0051956) | 2.99817129 |
| 136 | fear response (GO:0042596) | 2.99539026 |
| 137 | startle response (GO:0001964) | 2.99128716 |
| 138 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.98985790 |
| 139 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.97248010 |
| 140 | regulation of dendritic spine development (GO:0060998) | 2.96887233 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.91581732 |
| 142 | peptidyl-threonine modification (GO:0018210) | 2.91254513 |
| 143 | growth hormone receptor signaling pathway (GO:0060396) | 2.90826944 |
| 144 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.89911218 |
| 145 | peptidyl-threonine phosphorylation (GO:0018107) | 2.89559170 |
| 146 | iron ion import (GO:0097286) | 2.88884624 |
| 147 | Golgi to plasma membrane transport (GO:0006893) | 2.87422408 |
| 148 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.86667231 |
| 149 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.84974628 |
| 150 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.83780211 |
| 151 | peptidyl-lysine dimethylation (GO:0018027) | 2.80582436 |
| 152 | astrocyte development (GO:0014002) | 2.80383739 |
| 153 | regulation of ARF protein signal transduction (GO:0032012) | 2.79030049 |
| 154 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.78291605 |
| 155 | negative regulation of neurotransmitter transport (GO:0051589) | 2.74288383 |
| 156 | hepatocyte apoptotic process (GO:0097284) | 2.73453255 |
| 157 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.70816488 |
| 158 | hemidesmosome assembly (GO:0031581) | 2.70255663 |
| 159 | replicative senescence (GO:0090399) | 2.68556587 |
| 160 | phospholipid homeostasis (GO:0055091) | 2.65867202 |
| 161 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.64960058 |
| 162 | Golgi to plasma membrane protein transport (GO:0043001) | 2.64908672 |
| 163 | positive regulation of developmental pigmentation (GO:0048087) | 2.64451090 |
| 164 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.63893537 |
| 165 | peptidyl-serine phosphorylation (GO:0018105) | 2.63329734 |
| 166 | cellular response to growth hormone stimulus (GO:0071378) | 2.61453477 |
| 167 | regulation of protein kinase A signaling (GO:0010738) | 2.61433337 |
| 168 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.60638518 |
| 169 | positive regulation of receptor recycling (GO:0001921) | 2.59991474 |
| 170 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.59555385 |
| 171 | establishment of protein localization to Golgi (GO:0072600) | 2.56565804 |
| 172 | mucosal immune response (GO:0002385) | 2.56111991 |
| 173 | pre-miRNA processing (GO:0031054) | 2.55676574 |
| 174 | microglial cell activation (GO:0001774) | 2.54439416 |
| 175 | L-amino acid import (GO:0043092) | 2.53589538 |
| 176 | import into cell (GO:0098657) | 2.52915629 |
| 177 | myelination (GO:0042552) | 2.52801711 |
| 178 | antibacterial humoral response (GO:0019731) | 2.52499771 |
| 179 | cellular response to epinephrine stimulus (GO:0071872) | 2.52161688 |
| 180 | cortical actin cytoskeleton organization (GO:0030866) | 2.49917837 |
| 181 | histone mRNA catabolic process (GO:0071044) | 2.47992470 |
| 182 | regulation of establishment of cell polarity (GO:2000114) | 2.47738101 |
| 183 | macrophage activation (GO:0042116) | 2.46006440 |
| 184 | protein K11-linked deubiquitination (GO:0035871) | 2.45892341 |
| 185 | peptidyl-serine modification (GO:0018209) | 2.45514546 |
| 186 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.45443813 |
| 187 | histone lysine demethylation (GO:0070076) | 2.45043613 |
| 188 | organ or tissue specific immune response (GO:0002251) | 2.44391750 |
| 189 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.43663936 |
| 190 | hypotonic response (GO:0006971) | 2.42469473 |
| 191 | regulation of response to reactive oxygen species (GO:1901031) | 2.40450708 |
| 192 | neural tube formation (GO:0001841) | 2.39827862 |
| 193 | centrosome localization (GO:0051642) | 2.39160605 |
| 194 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.38595001 |
| 195 | protein targeting to vacuole (GO:0006623) | 2.38317279 |
| 196 | protein targeting to lysosome (GO:0006622) | 2.38317279 |
| 197 | establishment of protein localization to vacuole (GO:0072666) | 2.38317279 |
| 198 | polyol biosynthetic process (GO:0046173) | 2.38181766 |
| 199 | determination of adult lifespan (GO:0008340) | 2.35596974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.09825427 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.85489277 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.36446257 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.91404719 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.28710149 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17363904 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07291712 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.05824845 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.92482750 |
| 10 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.91231565 |
| 11 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.74602567 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70948364 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69879953 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69879953 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65334102 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55794631 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55538672 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54266012 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53096073 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52147237 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.42306346 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.40753595 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38011601 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37354119 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30598564 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30242031 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.28627364 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26920463 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17554612 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15930929 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 2.15426765 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12237105 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09467752 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02317319 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02050039 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01702492 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87766612 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86476348 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81880367 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77276001 |
| 41 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75377496 |
| 42 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.68451642 |
| 43 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.68384420 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66998554 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65440583 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58486731 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57389366 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57389366 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57347420 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57175421 |
| 51 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.53173916 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.53102123 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52662900 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50886311 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49359090 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45862820 |
| 57 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42696048 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42136055 |
| 59 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41622242 |
| 60 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.39006698 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38795890 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38745220 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36661808 |
| 64 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36117471 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35094390 |
| 66 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35086420 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34844064 |
| 68 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.34364355 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32038022 |
| 70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30844227 |
| 71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29297115 |
| 72 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.28980989 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28942127 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26079412 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26061783 |
| 76 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24413898 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23969042 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23504303 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22425201 |
| 80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21665385 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21662821 |
| 82 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21558593 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21544696 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20589234 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20456720 |
| 86 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20440045 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20399627 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20380373 |
| 89 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19996436 |
| 90 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19373473 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18205434 |
| 92 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17271070 |
| 93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16975494 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16975317 |
| 95 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16970123 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16140125 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16117516 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 1.15756525 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15593699 |
| 100 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12300916 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11773380 |
| 102 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11597584 |
| 103 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09883012 |
| 104 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08438783 |
| 105 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08225205 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07815496 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06477595 |
| 108 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05375314 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03481756 |
| 110 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03371859 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02886909 |
| 112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02752964 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02131305 |
| 114 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01071419 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01043791 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01037657 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00596045 |
| 118 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99410309 |
| 119 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99193306 |
| 120 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99091778 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98996539 |
| 122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98996539 |
| 123 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98908783 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98884801 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98013518 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97995906 |
| 127 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97503993 |
| 128 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97143932 |
| 129 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97068732 |
| 130 | JUN_21703547_ChIP-Seq_K562_Human | 0.96675677 |
| 131 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96527317 |
| 132 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95995450 |
| 133 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95978168 |
| 134 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95445027 |
| 135 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94852632 |
| 136 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93850814 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93480640 |
| 138 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93437138 |
| 139 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93383950 |
| 140 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92894402 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92733593 |
| 142 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91845744 |
| 143 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91456045 |
| 144 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91003731 |
| 145 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90637835 |
| 146 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90317813 |
| 147 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90284405 |
| 148 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90171587 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90171367 |
| 150 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90004421 |
| 151 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89297101 |
| 152 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.88506873 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88213592 |
| 154 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87917649 |
| 155 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.87904116 |
| 156 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86730726 |
| 157 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86603195 |
| 158 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86454654 |
| 159 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85673553 |
| 160 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83712041 |
| 161 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83464384 |
| 162 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83323602 |
| 163 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82667696 |
| 164 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82534853 |
| 165 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81684725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.20953298 |
| 2 | MP0003880_abnormal_central_pattern | 5.24453636 |
| 3 | MP0008057_abnormal_DNA_replication | 4.46181822 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.21248664 |
| 5 | MP0009745_abnormal_behavioral_response | 3.66792216 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.52900083 |
| 7 | MP0004270_analgesia | 3.50552816 |
| 8 | MP0002064_seizures | 3.41443114 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.39679441 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.39359867 |
| 11 | MP0002822_catalepsy | 3.33379331 |
| 12 | MP0009046_muscle_twitch | 3.29441785 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.96231931 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.90666010 |
| 15 | MP0002009_preneoplasia | 2.77802031 |
| 16 | MP0002272_abnormal_nervous_system | 2.71345697 |
| 17 | MP0002736_abnormal_nociception_after | 2.68067164 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.65112233 |
| 19 | MP0001486_abnormal_startle_reflex | 2.55530604 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.49736948 |
| 21 | MP0000015_abnormal_ear_pigmentation | 2.44233682 |
| 22 | MP0008260_abnormal_autophagy | 2.39776324 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.33998302 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.26635265 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.24568826 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.23101016 |
| 27 | MP0010678_abnormal_skin_adnexa | 2.18646401 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.18357359 |
| 29 | MP0005171_absent_coat_pigmentation | 2.13637343 |
| 30 | MP0005174_abnormal_tail_pigmentation | 2.13295199 |
| 31 | MP0002067_abnormal_sensory_capabilities | 2.06167567 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.99975494 |
| 33 | MP0001970_abnormal_pain_threshold | 1.99739497 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.99401523 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.97227947 |
| 36 | MP0004130_abnormal_muscle_cell | 1.91934195 |
| 37 | MP0003091_abnormal_cell_migration | 1.91558100 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.86260132 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.85808752 |
| 40 | MP0000383_abnormal_hair_follicle | 1.85755454 |
| 41 | MP0004924_abnormal_behavior | 1.82188250 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.82188250 |
| 43 | MP0005408_hypopigmentation | 1.81921404 |
| 44 | MP0003879_abnormal_hair_cell | 1.81408205 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.80960993 |
| 46 | MP0008569_lethality_at_weaning | 1.77594256 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.76038343 |
| 48 | MP0003787_abnormal_imprinting | 1.71173689 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.69715731 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.67086189 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.66052267 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.65309565 |
| 53 | MP0003868_abnormal_feces_composition | 1.64332974 |
| 54 | MP0001529_abnormal_vocalization | 1.62852553 |
| 55 | MP0002184_abnormal_innervation | 1.61904672 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.61376196 |
| 57 | MP0003329_amyloid_beta_deposits | 1.61351073 |
| 58 | MP0000537_abnormal_urethra_morphology | 1.59698745 |
| 59 | MP0003122_maternal_imprinting | 1.59436741 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.58871634 |
| 61 | MP0000371_diluted_coat_color | 1.58833466 |
| 62 | MP0001958_emphysema | 1.57887032 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.57486505 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.55591691 |
| 65 | MP0005248_abnormal_Harderian_gland | 1.55172235 |
| 66 | MP0004381_abnormal_hair_follicle | 1.54572733 |
| 67 | MP0001984_abnormal_olfaction | 1.52639898 |
| 68 | MP0001905_abnormal_dopamine_level | 1.51220119 |
| 69 | MP0000778_abnormal_nervous_system | 1.47719175 |
| 70 | MP0003045_fibrosis | 1.47310608 |
| 71 | MP0004858_abnormal_nervous_system | 1.47204521 |
| 72 | MP0001299_abnormal_eye_distance/ | 1.47165631 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.44447270 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.42574891 |
| 75 | MP0006054_spinal_hemorrhage | 1.40209337 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 1.39557105 |
| 77 | MP0005187_abnormal_penis_morphology | 1.37554873 |
| 78 | MP0003633_abnormal_nervous_system | 1.36324295 |
| 79 | MP0000955_abnormal_spinal_cord | 1.36019342 |
| 80 | MP0005409_darkened_coat_color | 1.35637986 |
| 81 | MP0005645_abnormal_hypothalamus_physiol | 1.34562532 |
| 82 | MP0004142_abnormal_muscle_tone | 1.33848725 |
| 83 | MP0001915_intracranial_hemorrhage | 1.31609300 |
| 84 | MP0002882_abnormal_neuron_morphology | 1.31165441 |
| 85 | MP0002006_tumorigenesis | 1.30468734 |
| 86 | MP0008872_abnormal_physiological_respon | 1.24173076 |
| 87 | MP0005666_abnormal_adipose_tissue | 1.23119661 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 1.20535241 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.18636194 |
| 90 | MP0003828_pulmonary_edema | 1.17568086 |
| 91 | MP0001188_hyperpigmentation | 1.16665331 |
| 92 | MP0004036_abnormal_muscle_relaxation | 1.15673504 |
| 93 | MP0003724_increased_susceptibility_to | 1.14520875 |
| 94 | MP0002396_abnormal_hematopoietic_system | 1.14446218 |
| 95 | MP0000751_myopathy | 1.12769895 |
| 96 | MP0003631_nervous_system_phenotype | 1.12580635 |
| 97 | MP0005275_abnormal_skin_tensile | 1.11424693 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 1.09799011 |
| 99 | MP0000013_abnormal_adipose_tissue | 1.08188766 |
| 100 | MP0004885_abnormal_endolymph | 1.07622281 |
| 101 | MP0010386_abnormal_urinary_bladder | 1.07259718 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 1.06671144 |
| 103 | MP0000428_abnormal_craniofacial_morphol | 1.06013205 |
| 104 | MP0000427_abnormal_hair_cycle | 1.04900463 |
| 105 | MP0003191_abnormal_cellular_cholesterol | 1.02165267 |
| 106 | MP0002876_abnormal_thyroid_physiology | 1.01986981 |
| 107 | MP0000733_abnormal_muscle_development | 0.99806187 |
| 108 | MP0008874_decreased_physiological_sensi | 0.99148089 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.98246242 |
| 110 | MP0002152_abnormal_brain_morphology | 0.97596695 |
| 111 | MP0005451_abnormal_body_composition | 0.97466249 |
| 112 | MP0003763_abnormal_thymus_physiology | 0.96872257 |
| 113 | MP0005388_respiratory_system_phenotype | 0.96084897 |
| 114 | MP0002133_abnormal_respiratory_system | 0.96084897 |
| 115 | MP0001661_extended_life_span | 0.95612649 |
| 116 | MP0003303_peritoneal_inflammation | 0.95514525 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.94708872 |
| 118 | MP0003866_abnormal_defecation | 0.94527703 |
| 119 | MP0005535_abnormal_body_temperature | 0.92600048 |
| 120 | MP0005023_abnormal_wound_healing | 0.92142496 |
| 121 | MP0002229_neurodegeneration | 0.90356791 |
| 122 | MP0000377_abnormal_hair_follicle | 0.86720812 |
| 123 | MP0004085_abnormal_heartbeat | 0.84983307 |
| 124 | MP0004742_abnormal_vestibular_system | 0.83805465 |
| 125 | MP0004947_skin_inflammation | 0.83661066 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.82793083 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.81384543 |
| 128 | MP0010307_abnormal_tumor_latency | 0.80889627 |
| 129 | MP0004145_abnormal_muscle_electrophysio | 0.80712849 |
| 130 | MP0000003_abnormal_adipose_tissue | 0.79843532 |
| 131 | MP0001177_atelectasis | 0.79826303 |
| 132 | MP0002933_joint_inflammation | 0.79711091 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.77806089 |
| 134 | MP0003075_altered_response_to | 0.77432534 |
| 135 | MP0002090_abnormal_vision | 0.76003684 |
| 136 | MP0001664_abnormal_digestion | 0.75244535 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.74098410 |
| 138 | MP0004084_abnormal_cardiac_muscle | 0.73535080 |
| 139 | MP0000631_abnormal_neuroendocrine_gland | 0.72703029 |
| 140 | MP0004215_abnormal_myocardial_fiber | 0.72244958 |
| 141 | MP0003690_abnormal_glial_cell | 0.72199643 |
| 142 | MP0004043_abnormal_pH_regulation | 0.71722912 |
| 143 | MP0004484_altered_response_of | 0.70260379 |
| 144 | MP0000747_muscle_weakness | 0.69730647 |
| 145 | MP0005499_abnormal_olfactory_system | 0.69728862 |
| 146 | MP0005394_taste/olfaction_phenotype | 0.69728862 |
| 147 | MP0008961_abnormal_basal_metabolism | 0.69612154 |
| 148 | MP0001851_eye_inflammation | 0.68911535 |
| 149 | MP0005621_abnormal_cell_physiology | 0.68902155 |
| 150 | MP0001186_pigmentation_phenotype | 0.68523478 |
| 151 | MP0003632_abnormal_nervous_system | 0.68057701 |
| 152 | MP0000749_muscle_degeneration | 0.67402815 |
| 153 | MP0000604_amyloidosis | 0.67188734 |
| 154 | MP0002752_abnormal_somatic_nervous | 0.65223144 |
| 155 | MP0003634_abnormal_glial_cell | 0.65092921 |
| 156 | MP0002638_abnormal_pupillary_reflex | 0.64500294 |
| 157 | MP0004233_abnormal_muscle_weight | 0.64442531 |
| 158 | MP0000569_abnormal_digit_pigmentation | 0.64419267 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.64200975 |
| 160 | MP0002168_other_aberrant_phenotype | 0.63491928 |
| 161 | MP0002269_muscular_atrophy | 0.63218344 |
| 162 | MP0004134_abnormal_chest_morphology | 0.63039492 |
| 163 | MP0002075_abnormal_coat/hair_pigmentati | 0.61698741 |
| 164 | MP0000372_irregular_coat_pigmentation | 0.61470824 |
| 165 | MP0003941_abnormal_skin_development | 0.60328627 |
| 166 | MP0005623_abnormal_meninges_morphology | 0.59233215 |
| 167 | MP0003123_paternal_imprinting | 0.58319684 |
| 168 | MP0000920_abnormal_myelination | 0.57517985 |
| 169 | MP0005167_abnormal_blood-brain_barrier | 0.56718989 |
| 170 | MP0001943_abnormal_respiration | 0.55685244 |
| 171 | MP0002896_abnormal_bone_mineralization | 0.55254417 |
| 172 | MP0001485_abnormal_pinna_reflex | 0.55200163 |
| 173 | MP0003121_genomic_imprinting | 0.54807815 |
| 174 | MP0003283_abnormal_digestive_organ | 0.52621468 |
| 175 | MP0008877_abnormal_DNA_methylation | 0.50493597 |
| 176 | MP0003956_abnormal_body_size | 0.49992977 |
| 177 | MP0003137_abnormal_impulse_conducting | 0.49241107 |
| 178 | MP0010769_abnormal_survival | 0.48805981 |
| 179 | MP0010770_preweaning_lethality | 0.48674924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.97112426 |
| 2 | Myokymia (HP:0002411) | 6.69222631 |
| 3 | Focal seizures (HP:0007359) | 6.05723103 |
| 4 | Atonic seizures (HP:0010819) | 5.95574886 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.84400440 |
| 6 | Visual hallucinations (HP:0002367) | 5.37940062 |
| 7 | Febrile seizures (HP:0002373) | 5.37723220 |
| 8 | Absence seizures (HP:0002121) | 4.88155028 |
| 9 | Papillary thyroid carcinoma (HP:0002895) | 4.65888033 |
| 10 | Dialeptic seizures (HP:0011146) | 4.46345318 |
| 11 | Hyperventilation (HP:0002883) | 4.38942246 |
| 12 | Colitis (HP:0002583) | 4.38509502 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 4.28021322 |
| 14 | Subacute progressive viral hepatitis (HP:0006572) | 4.16303230 |
| 15 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.11260132 |
| 16 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.09356081 |
| 17 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.09356081 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 4.03509901 |
| 19 | Interstitial pulmonary disease (HP:0006530) | 3.86333107 |
| 20 | Broad-based gait (HP:0002136) | 3.81209122 |
| 21 | IgM deficiency (HP:0002850) | 3.67142996 |
| 22 | Thyroiditis (HP:0100646) | 3.63326737 |
| 23 | Poor eye contact (HP:0000817) | 3.51198482 |
| 24 | Abnormal eating behavior (HP:0100738) | 3.43168499 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 3.39244713 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.36347505 |
| 27 | Action tremor (HP:0002345) | 3.25138274 |
| 28 | Dysdiadochokinesis (HP:0002075) | 3.23299700 |
| 29 | Difficulty running (HP:0009046) | 3.22763793 |
| 30 | Depression (HP:0000716) | 3.17031507 |
| 31 | Amblyopia (HP:0000646) | 3.15865894 |
| 32 | Abnormal social behavior (HP:0012433) | 3.13490931 |
| 33 | Impaired social interactions (HP:0000735) | 3.13490931 |
| 34 | IgA deficiency (HP:0002720) | 3.07708461 |
| 35 | Anxiety (HP:0000739) | 3.07088773 |
| 36 | Ankle clonus (HP:0011448) | 3.04539970 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.99242883 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.94462196 |
| 39 | Truncal ataxia (HP:0002078) | 2.91951336 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.87109616 |
| 41 | Progressive inability to walk (HP:0002505) | 2.86980069 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.86163216 |
| 43 | Dysmetria (HP:0001310) | 2.84186510 |
| 44 | Postural instability (HP:0002172) | 2.80058543 |
| 45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.74896242 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.74896242 |
| 47 | Polyphagia (HP:0002591) | 2.71621483 |
| 48 | Short chin (HP:0000331) | 2.71493550 |
| 49 | Pheochromocytoma (HP:0002666) | 2.70988798 |
| 50 | Bradykinesia (HP:0002067) | 2.58225181 |
| 51 | Excessive salivation (HP:0003781) | 2.57779520 |
| 52 | Drooling (HP:0002307) | 2.57779520 |
| 53 | Inability to walk (HP:0002540) | 2.56546404 |
| 54 | Urinary urgency (HP:0000012) | 2.56109616 |
| 55 | Dysmetric saccades (HP:0000641) | 2.56073053 |
| 56 | Epileptiform EEG discharges (HP:0011182) | 2.55571612 |
| 57 | Impaired smooth pursuit (HP:0007772) | 2.51463430 |
| 58 | Papilledema (HP:0001085) | 2.50914792 |
| 59 | Status epilepticus (HP:0002133) | 2.50420429 |
| 60 | Gingivitis (HP:0000230) | 2.47102547 |
| 61 | Neuroendocrine neoplasm (HP:0100634) | 2.46308857 |
| 62 | Torticollis (HP:0000473) | 2.45999033 |
| 63 | Abnormality of the lower motor neuron (HP:0002366) | 2.45746858 |
| 64 | Limb dystonia (HP:0002451) | 2.43512066 |
| 65 | Viral hepatitis (HP:0006562) | 2.42980150 |
| 66 | Resting tremor (HP:0002322) | 2.42899674 |
| 67 | Mutism (HP:0002300) | 2.40667150 |
| 68 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.40395307 |
| 69 | T lymphocytopenia (HP:0005403) | 2.39878072 |
| 70 | Germ cell neoplasia (HP:0100728) | 2.39129812 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.39015153 |
| 72 | Spastic gait (HP:0002064) | 2.38658458 |
| 73 | Failure to thrive in infancy (HP:0001531) | 2.37205795 |
| 74 | Focal dystonia (HP:0004373) | 2.36221296 |
| 75 | Vertebral arch anomaly (HP:0008438) | 2.35491376 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.35144807 |
| 77 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34813835 |
| 78 | Hemiparesis (HP:0001269) | 2.34529364 |
| 79 | Scanning speech (HP:0002168) | 2.34195515 |
| 80 | Termporal pattern (HP:0011008) | 2.34005327 |
| 81 | Insidious onset (HP:0003587) | 2.34005327 |
| 82 | Stereotypic behavior (HP:0000733) | 2.33991713 |
| 83 | Abnormal hair whorl (HP:0010721) | 2.33564661 |
| 84 | Impaired vibratory sensation (HP:0002495) | 2.33066415 |
| 85 | Genetic anticipation (HP:0003743) | 2.31742883 |
| 86 | Hyporeflexia of lower limbs (HP:0002600) | 2.26899773 |
| 87 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.25850790 |
| 88 | Neonatal hypoglycemia (HP:0001998) | 2.25274918 |
| 89 | Diplopia (HP:0000651) | 2.24701475 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.24701475 |
| 91 | Protruding tongue (HP:0010808) | 2.24535483 |
| 92 | Absent speech (HP:0001344) | 2.24441556 |
| 93 | Overgrowth (HP:0001548) | 2.21918337 |
| 94 | Generalized myoclonic seizures (HP:0002123) | 2.21869845 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.19159865 |
| 96 | Acute myeloid leukemia (HP:0004808) | 2.18812882 |
| 97 | Hemiplegia (HP:0002301) | 2.18660237 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 2.18366781 |
| 99 | Onion bulb formation (HP:0003383) | 2.18357896 |
| 100 | Large earlobe (HP:0009748) | 2.16415220 |
| 101 | Hypoventilation (HP:0002791) | 2.15120163 |
| 102 | Recurrent bacterial skin infections (HP:0005406) | 2.14190693 |
| 103 | Delusions (HP:0000746) | 2.13234968 |
| 104 | Ventricular fibrillation (HP:0001663) | 2.12790905 |
| 105 | Heterotopia (HP:0002282) | 2.12700119 |
| 106 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12604032 |
| 107 | Craniofacial dystonia (HP:0012179) | 2.12359409 |
| 108 | Medulloblastoma (HP:0002885) | 2.11944754 |
| 109 | Abnormality of T cell number (HP:0011839) | 2.11543955 |
| 110 | Decreased motor nerve conduction velocity (HP:0003431) | 2.08674526 |
| 111 | Cellulitis (HP:0100658) | 2.08665674 |
| 112 | Sandal gap (HP:0001852) | 2.08391445 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 2.08172172 |
| 114 | Blue irides (HP:0000635) | 2.07579542 |
| 115 | Decreased lacrimation (HP:0000633) | 2.06182532 |
| 116 | Conjunctival telangiectasia (HP:0000524) | 2.05877219 |
| 117 | Abnormal glucose tolerance (HP:0001952) | 2.03150081 |
| 118 | Submucous cleft hard palate (HP:0000176) | 2.02972933 |
| 119 | Gastrointestinal inflammation (HP:0004386) | 2.02707838 |
| 120 | Menstrual irregularities (HP:0000858) | 2.02212702 |
| 121 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.02126239 |
| 122 | Incomplete penetrance (HP:0003829) | 2.00890720 |
| 123 | Lower limb muscle weakness (HP:0007340) | 2.00651405 |
| 124 | Fair hair (HP:0002286) | 2.00558589 |
| 125 | Hyperthyroidism (HP:0000836) | 2.00478332 |
| 126 | Gait imbalance (HP:0002141) | 2.00374690 |
| 127 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.99814556 |
| 128 | Poor suck (HP:0002033) | 1.99220114 |
| 129 | Relative macrocephaly (HP:0004482) | 1.98219929 |
| 130 | Lower limb amyotrophy (HP:0007210) | 1.98179729 |
| 131 | Intention tremor (HP:0002080) | 1.97819061 |
| 132 | Annular pancreas (HP:0001734) | 1.96799028 |
| 133 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96402036 |
| 134 | Gait ataxia (HP:0002066) | 1.96302679 |
| 135 | Hypoplasia of the iris (HP:0007676) | 1.96216929 |
| 136 | Micronodular cirrhosis (HP:0001413) | 1.94679925 |
| 137 | Specific learning disability (HP:0001328) | 1.94507899 |
| 138 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.93393465 |
| 139 | Alacrima (HP:0000522) | 1.92766547 |
| 140 | Pelvic girdle muscle weakness (HP:0003749) | 1.92358872 |
| 141 | Thoracolumbar scoliosis (HP:0002944) | 1.92194055 |
| 142 | Psychosis (HP:0000709) | 1.89060113 |
| 143 | Sleep apnea (HP:0010535) | 1.87417492 |
| 144 | Abnormality of the corticospinal tract (HP:0002492) | 1.87168624 |
| 145 | Abnormality of the fingertips (HP:0001211) | 1.86727521 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.86153143 |
| 147 | Narrow palate (HP:0000189) | 1.85858369 |
| 148 | Flat acetabular roof (HP:0003180) | 1.85586918 |
| 149 | Hepatoblastoma (HP:0002884) | 1.85557927 |
| 150 | Neoplasm of the heart (HP:0100544) | 1.84215556 |
| 151 | Rigidity (HP:0002063) | 1.83473219 |
| 152 | Distal lower limb amyotrophy (HP:0008944) | 1.82591068 |
| 153 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.82372297 |
| 154 | Spinal muscular atrophy (HP:0007269) | 1.81709302 |
| 155 | Abnormal auditory evoked potentials (HP:0006958) | 1.80975452 |
| 156 | Broad ribs (HP:0000885) | 1.80705221 |
| 157 | Oligomenorrhea (HP:0000876) | 1.79265662 |
| 158 | Absent frontal sinuses (HP:0002688) | 1.78122807 |
| 159 | Agitation (HP:0000713) | 1.77923091 |
| 160 | Narrow nasal bridge (HP:0000446) | 1.77374801 |
| 161 | Esotropia (HP:0000565) | 1.76711542 |
| 162 | Ankyloglossia (HP:0010296) | 1.76117572 |
| 163 | Frequent falls (HP:0002359) | 1.75330399 |
| 164 | Congenital primary aphakia (HP:0007707) | 1.74780291 |
| 165 | Stomach cancer (HP:0012126) | 1.74557037 |
| 166 | Generalized hypotonia (HP:0001290) | 1.73560092 |
| 167 | Curly hair (HP:0002212) | 1.73525369 |
| 168 | Abnormality of the periventricular white matter (HP:0002518) | 1.73491399 |
| 169 | Abnormality of saccadic eye movements (HP:0000570) | 1.73429906 |
| 170 | Abnormality of the labia minora (HP:0012880) | 1.72835637 |
| 171 | Abnormality of salivation (HP:0100755) | 1.72245735 |
| 172 | Aortic aneurysm (HP:0004942) | 1.71746578 |
| 173 | Glucose intolerance (HP:0000833) | 1.71596387 |
| 174 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.70697065 |
| 175 | Asymmetry of the thorax (HP:0001555) | 1.70373211 |
| 176 | Spastic paraplegia (HP:0001258) | 1.66679160 |
| 177 | Persistence of primary teeth (HP:0006335) | 1.65155249 |
| 178 | Hemangiomatosis (HP:0007461) | 1.64434425 |
| 179 | Periodontitis (HP:0000704) | 1.64407735 |
| 180 | Deep philtrum (HP:0002002) | 1.62238089 |
| 181 | Cubitus valgus (HP:0002967) | 1.61524192 |
| 182 | Lower limb hyperreflexia (HP:0002395) | 1.61358842 |
| 183 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.61000947 |
| 184 | Bowel incontinence (HP:0002607) | 1.60874396 |
| 185 | Spontaneous hematomas (HP:0007420) | 1.60459243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.45628567 |
| 2 | NTRK3 | 4.00049186 |
| 3 | CASK | 3.88108657 |
| 4 | MAP3K9 | 3.50549591 |
| 5 | DAPK2 | 3.30333843 |
| 6 | MAP3K4 | 3.14522701 |
| 7 | MAP3K12 | 2.90072478 |
| 8 | MAP2K7 | 2.80616734 |
| 9 | ZAK | 2.74871192 |
| 10 | TLK1 | 2.68536901 |
| 11 | TRIB3 | 2.47615474 |
| 12 | CDK19 | 2.41797653 |
| 13 | MINK1 | 2.32455877 |
| 14 | EPHA3 | 2.31576870 |
| 15 | FRK | 2.20610031 |
| 16 | DAPK1 | 2.18743838 |
| 17 | BLK | 2.12017754 |
| 18 | SCYL2 | 2.06609784 |
| 19 | FGFR3 | 2.04351106 |
| 20 | MAP2K4 | 2.02609715 |
| 21 | PAK6 | 2.02249110 |
| 22 | PLK2 | 1.96070537 |
| 23 | PIK3CG | 1.95142976 |
| 24 | MARK1 | 1.94702559 |
| 25 | KSR2 | 1.82584924 |
| 26 | NTRK2 | 1.77113236 |
| 27 | RIPK4 | 1.75053535 |
| 28 | CAMKK1 | 1.71799290 |
| 29 | ARAF | 1.68079675 |
| 30 | PBK | 1.67609649 |
| 31 | PRKD3 | 1.67467617 |
| 32 | GRK5 | 1.65197879 |
| 33 | NTRK1 | 1.63730890 |
| 34 | CCNB1 | 1.60297386 |
| 35 | EEF2K | 1.59998108 |
| 36 | MAP3K6 | 1.58442023 |
| 37 | PRPF4B | 1.55299517 |
| 38 | FGFR2 | 1.49907798 |
| 39 | ACVR1B | 1.46742168 |
| 40 | CDK5 | 1.44339587 |
| 41 | KSR1 | 1.40133279 |
| 42 | MET | 1.38642416 |
| 43 | TTN | 1.36447243 |
| 44 | CAMKK2 | 1.34825370 |
| 45 | RPS6KA5 | 1.31443285 |
| 46 | OXSR1 | 1.29064858 |
| 47 | STK39 | 1.28462632 |
| 48 | JAK1 | 1.27502624 |
| 49 | BTK | 1.25524032 |
| 50 | PNCK | 1.21849628 |
| 51 | OBSCN | 1.20453689 |
| 52 | NEK9 | 1.18095302 |
| 53 | PRKCG | 1.16082074 |
| 54 | MAPK13 | 1.13955865 |
| 55 | MAP3K13 | 1.13817753 |
| 56 | TNIK | 1.13144774 |
| 57 | FES | 1.12609561 |
| 58 | CDK6 | 1.12526614 |
| 59 | PKN2 | 1.12091407 |
| 60 | AKT3 | 1.11775508 |
| 61 | IRAK1 | 1.10777429 |
| 62 | PDGFRB | 1.10480459 |
| 63 | PDGFRA | 1.08911201 |
| 64 | IRAK2 | 1.04527818 |
| 65 | SGK223 | 1.02467578 |
| 66 | SGK494 | 1.02467578 |
| 67 | MAP3K2 | 1.01853795 |
| 68 | STK38 | 1.01518160 |
| 69 | UHMK1 | 1.01101434 |
| 70 | CAMK2A | 1.00929198 |
| 71 | ERBB3 | 1.00297093 |
| 72 | SIK2 | 1.00174851 |
| 73 | STK4 | 0.99441495 |
| 74 | JAK2 | 0.98598468 |
| 75 | MAP2K3 | 0.95929007 |
| 76 | PIM1 | 0.93171832 |
| 77 | TRPM7 | 0.92759541 |
| 78 | CDK18 | 0.92709251 |
| 79 | TYRO3 | 0.92322366 |
| 80 | MAP3K10 | 0.90575581 |
| 81 | SGK2 | 0.89932124 |
| 82 | PTK2B | 0.89704385 |
| 83 | CDK15 | 0.88837708 |
| 84 | CAMK1D | 0.87627342 |
| 85 | CAMK1 | 0.85847760 |
| 86 | CDK14 | 0.85663288 |
| 87 | ERBB2 | 0.84955313 |
| 88 | STK11 | 0.82022304 |
| 89 | CAMK2B | 0.80966021 |
| 90 | TNK2 | 0.78112610 |
| 91 | RPS6KB2 | 0.78089393 |
| 92 | TAOK1 | 0.77807079 |
| 93 | DAPK3 | 0.77120941 |
| 94 | CDK11A | 0.76907014 |
| 95 | BMPR2 | 0.74944347 |
| 96 | NME1 | 0.74558362 |
| 97 | NLK | 0.73283905 |
| 98 | ICK | 0.72615063 |
| 99 | HCK | 0.72593033 |
| 100 | EGFR | 0.71745834 |
| 101 | RAF1 | 0.71373772 |
| 102 | PRKCH | 0.70189286 |
| 103 | MELK | 0.69734491 |
| 104 | RPS6KB1 | 0.69575698 |
| 105 | BRAF | 0.69196865 |
| 106 | SGK3 | 0.68235739 |
| 107 | PINK1 | 0.67471065 |
| 108 | WNK1 | 0.67007517 |
| 109 | SYK | 0.66957970 |
| 110 | FGFR4 | 0.65989432 |
| 111 | NEK1 | 0.64527117 |
| 112 | CSK | 0.64363398 |
| 113 | BRD4 | 0.63280391 |
| 114 | CAMK1G | 0.63262967 |
| 115 | SGK1 | 0.62942579 |
| 116 | IKBKE | 0.62877351 |
| 117 | MST1R | 0.61576976 |
| 118 | RET | 0.61349192 |
| 119 | LATS1 | 0.59946919 |
| 120 | SIK3 | 0.59294081 |
| 121 | PDK1 | 0.58268750 |
| 122 | MAPK11 | 0.57708976 |
| 123 | PDPK1 | 0.56337190 |
| 124 | MAP3K1 | 0.55985374 |
| 125 | PRKCE | 0.55707004 |
| 126 | LATS2 | 0.55579232 |
| 127 | DYRK1A | 0.55306697 |
| 128 | PDK4 | 0.54880052 |
| 129 | PDK3 | 0.54880052 |
| 130 | PHKG2 | 0.54263069 |
| 131 | PHKG1 | 0.54263069 |
| 132 | STK38L | 0.53782923 |
| 133 | TEC | 0.51937344 |
| 134 | PIK3CA | 0.51816614 |
| 135 | PRKAA2 | 0.51635311 |
| 136 | PAK3 | 0.50274168 |
| 137 | CAMK2G | 0.49398661 |
| 138 | CAMK2D | 0.49284153 |
| 139 | LMTK2 | 0.48749042 |
| 140 | FGR | 0.48414081 |
| 141 | CSNK1G2 | 0.48237371 |
| 142 | ILK | 0.46924545 |
| 143 | CAMK4 | 0.45554013 |
| 144 | IRAK4 | 0.43364911 |
| 145 | CSNK1A1L | 0.43286698 |
| 146 | MAP2K1 | 0.42688939 |
| 147 | FGFR1 | 0.41916709 |
| 148 | TSSK6 | 0.41186686 |
| 149 | LCK | 0.41009589 |
| 150 | RPS6KA3 | 0.40738705 |
| 151 | MTOR | 0.40496799 |
| 152 | GRK6 | 0.40081094 |
| 153 | PRKAA1 | 0.40072719 |
| 154 | ADRBK1 | 0.39555496 |
| 155 | FER | 0.37365382 |
| 156 | ALK | 0.36394712 |
| 157 | WNK3 | 0.34688133 |
| 158 | BRSK1 | 0.34289625 |
| 159 | NEK6 | 0.34155492 |
| 160 | FYN | 0.33184389 |
| 161 | MARK2 | 0.33182043 |
| 162 | PRKCZ | 0.32737547 |
| 163 | MAPK10 | 0.32230776 |
| 164 | MUSK | 0.31024491 |
| 165 | MAPK12 | 0.30650870 |
| 166 | MAP3K7 | 0.30318044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.71824052 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.10117154 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.94067949 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.87855063 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.77140022 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75314097 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.62158374 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.61748604 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.57768053 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.56211579 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.46162415 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44679921 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16369635 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.10923999 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09387169 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.07854441 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82922364 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79609287 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.78580572 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.73885964 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71842776 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70308557 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68549368 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.62916319 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62751142 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.58111967 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57992481 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57575488 |
| 29 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.55580200 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.54289460 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51972853 |
| 32 | Endometrial cancer_Homo sapiens_hsa05213 | 1.51904995 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51225588 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43989552 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38566873 |
| 36 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.36037000 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33897866 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33163388 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30860382 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.30718928 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.25642178 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.24578195 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.24474134 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24223827 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21233866 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18740009 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16880007 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15974954 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15537252 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15052578 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14391586 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13631088 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.12594631 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 1.10202048 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09177709 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.07753059 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05039029 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04764040 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04367724 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03908604 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.01354713 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.00605408 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99671797 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.98693048 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98077343 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96913731 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96381344 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95828404 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.95424849 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.95052673 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93761128 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93471491 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92634088 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.91336419 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90511724 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.89222763 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87096431 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.85765340 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85545805 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85058215 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81004845 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78496196 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.78303713 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78138011 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.77306463 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77149426 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76007646 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74829502 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74247857 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.73768440 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71636224 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70945262 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70762938 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.70509394 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70254573 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.69417404 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69235588 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.67910619 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67494903 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67283777 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65870415 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65736915 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.65613351 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65085215 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65076435 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64916635 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64710848 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64138468 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63954457 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63117140 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62965003 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62411790 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62341451 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62189866 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61400607 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60174175 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.59487227 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59361841 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58704175 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58543831 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57456479 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57414554 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56497325 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56438785 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.53934205 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53498567 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53358167 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53174710 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.49529057 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49248636 |
| 131 | Tuberculosis_Homo sapiens_hsa05152 | 0.48997146 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48063578 |
| 133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47815667 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47439332 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47244241 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46217593 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42354471 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41394271 |
| 139 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40436374 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38791722 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38278221 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.38021092 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.36901511 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36751592 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.35402531 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33935634 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33019558 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32921235 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32087405 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31606292 |
| 151 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30762303 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.29490175 |
| 153 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28504039 |
| 154 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28367392 |
| 155 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27663240 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26796103 |
| 157 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26055752 |
| 158 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24730789 |
| 159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24397544 |

